EP
Eversept Partners’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.2M | Buy |
1,298,514
+741,444
| +133% | +$24.1M | 3.88% | 5 |
|
|
2025
Q1 | $21M | Buy |
557,070
+429,482
| +337% | +$16.2M | 2.14% | 13 |
|
|
2024
Q4 | $10.4M | Buy |
+127,588
| New | +$10.4M | 0.93% | 23 |
|
|
2024
Q3 | – | Sell |
-96,089
| Closed | -$7.26M | – | 77 |
|
|
2024
Q2 | $7.26M | Sell |
96,089
-101,242
| -51% | -$7.64M | 0.5% | 34 |
|
|
2024
Q1 | $13.5M | Sell |
197,331
-36,508
| -16% | -$2.49M | 0.9% | 20 |
|
|
2023
Q4 | $14.7M | Buy |
233,839
+43,409
| +23% | +$2.73M | 1.29% | 17 |
|
|
2023
Q3 | $9.71M | Sell |
190,430
-5,261
| -3% | -$268K | 0.82% | 22 |
|
|
2023
Q2 | $9.77M | Sell |
195,691
-103,359
| -35% | -$5.16M | 0.82% | 25 |
|
|
2023
Q1 | $11.2M | Buy |
299,050
+120,597
| +68% | +$4.52M | 0.78% | 25 |
|
|
2022
Q4 | $8.56M | Buy |
+178,453
| New | +$8.56M | 0.75% | 29 |
|